5:38 PM
Mar 22, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Multiple myeloma (MM)

Patient sample, cell culture and mouse studies suggest bispecific antibodies targeting CD3 and either BCMA or FCRL5 could help treat multiple myeloma (MM). In MM cells from patients and human MM...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD